Dr Hemanth Nandigala: ‘You cannot quicken the process of manufacturing vaccines too much’
3 years, 6 months ago

Dr Hemanth Nandigala: ‘You cannot quicken the process of manufacturing vaccines too much’

The Hindu  

technology is owned by the Russian Direct Investment Fund, is the only COVID-19 vaccine approved in India that is being manufactured locally from a diversified manufacturing base. Speaking to Frontline, Dr Hemanth Nandigala, managing director of the Hyderabad-based Virchow Biotech Private Limited, one of the Indian Sputnik V contractors, explains the constraints in scaling up capacity quickly. Excerpts from the interview: Virchow is one of the companies manufacturing the Sputnik V vaccine in India. The second dose of the Sputnik V vaccine is supposed to generate a higher level of efficacy than other similar two-dose vaccines because the antibody response is greater. Of course, producing two different doses of the vaccine is a logistical nightmare because it is almost like producing in two different locations because you don’t want cross-contamination.

Technology India Manufacturing Vaccines Raw Materials Vaccine Scale Dose Sputnik Rdif  quicken  vaccine  manufacturing  sputnik  dose  nandigala  second  doing  vaccines  scaling  technology  process  dr  scale  v  hemanth

History of this topic

Covid-19 Vaccine Sputnik V's India Production In A Fix After Sanctions on Russia's Jab Manufacturer
2 years, 9 months ago

Covid-19 Vaccine Sputnik V's India Production In A Fix After Sanctions on Russia's Jab Manufacturer

News 18  

The sanctions imposed by the United States on the Russian Direct Investment Fund, which markets Sputnik V internationally has raised concerns over the manufacturing of the Covid-19 vaccine in India, the second largest producer of the jab after Russia. RDIF is Russia’s sovereign wealth fund established in 2011 to make equity co-investments, primarily in Russia, alongside reputable international financial and …

Sputnik V hits production roadblock for second dose of Covid vaccine | Exclusive
3 years, 4 months ago

Sputnik V hits production roadblock for second dose of Covid vaccine | Exclusive

India Today  

Russia’s Sputnik V has reportedly hit a roadblock in the development of the second dose of its Covid-19 vaccine in India. "Production in India is expected to come fully onstream in September and RDIF expects India to become a major production hub for the Sputnik V vaccine with such companies as Serum Institute of India, the world’s biggest vaccine producer, …

Kerala plans to sign agreement with RDIF to fill Sputnik V vaccine vials
3 years, 5 months ago

Kerala plans to sign agreement with RDIF to fill Sputnik V vaccine vials

Hindustan Times  

Kerala may soon enter a deal with the Russian Direct Investment Fund, the country’s sovereign wealth fund, to set up a unit for filling Sputnik V Covid-19 vaccine vials, news agency ANI reported. The RDIF has entered into a partnership with Dr Reddy’s Labs to market the first 250 million doses of Sputnik V in India. Kerala industries principal secretary …

Serum Institute of India to start manufacturing Sputnik V in September, says RDIF
3 years, 5 months ago

Serum Institute of India to start manufacturing Sputnik V in September, says RDIF

Firstpost  

As per the agreement between the Russian Direct Investment Fund and Serum Institute, the parties intend to produce over 300 million doses of the vaccine in India per year New Delhi: Serum Institute of India will start production of Sputnik vaccine at the company’s facilities in September, Russian Direct Investment Fund said on Tuesday. As per the agreement between RDIF …

Serum Institute to produce Russia’s Sputnik V vaccine
3 years, 5 months ago

Serum Institute to produce Russia’s Sputnik V vaccine

The Hindu  

Serum Institute of India will be producing atleast 300 million doses of Sputnik V a year, with the first batch of the Russian vaccine against Covid-19 from its facility likely to be rolled out in September. These details emerged with the Russia’s sovereign wealth fund RDIF on Tuesday announcing a collaboration with the vaccine maker to manufacture Sputnik V for …

SII to produce 300 million doses of Sputnik V jabs annually
3 years, 5 months ago

SII to produce 300 million doses of Sputnik V jabs annually

Live Mint  

Russia’s sovereign wealth fund on Tuesday said it signed a manufacturing pact with Serum Institute of India, through which the world’s largest vaccine maker will produce more than 300 million doses of the Sputnik V vaccine a year. With high efficacy and a good safety profile, it is critical that the Sputnik vaccine is accessible in full measure for people …

Serum Institute to start production of Sputnik V vaccine in India from September
3 years, 5 months ago

Serum Institute to start production of Sputnik V vaccine in India from September

India Today  

The Russian Direct Investment Fund, Russia’s sovereign wealth fund, and Serum Institute of India have announced plans to start the production of the Sputnik V vaccine in India. The first batch of Sputnik V vaccine is expected to be produced at the Serum Institute’s facilities starting September. Kirill Dmitriev, CEO of the Russian Direct Investment Fund, said, “RDIF is delighted …

Single dose of Sputnik V vaccine enough for recovered Covid-19 patients: Study
3 years, 5 months ago

Single dose of Sputnik V vaccine enough for recovered Covid-19 patients: Study

India Today  

A day after scientists announced that mRNA vaccines are effective against the Delta variant of Covid-19, a single dose variant of Russia's Sputnik-V vaccine has shown 94 per cent efficacy among those recovered Covid-19 patients. The study published in the journal Science Direct states that 21 days after receiving the first dose of vaccine, 94 per cent of participants developed …

Sputnik V to offer booster shot to other manufacturers, adjusted to work against Delta variant
3 years, 6 months ago

Sputnik V to offer booster shot to other manufacturers, adjusted to work against Delta variant

India TV News  

Sputnik V will soon offer a booster shot, adjusted to work against the Delta variant of coronavirus to other vaccine manufacturers, the Russian vaccine maker announced on Thursday. Meanwhile, Dr Reddys Laboratories which has soft-launched Russias COVID-19 vaccine Sputnik V has expanded the pilot which is in the final leg to other cities such as Mumbai, Bangalore and New Delhi. …

Pharma company in Malta proposes to supply upto 60 mn Sputnik V doses, Haryana govt examining criteria
3 years, 6 months ago

Pharma company in Malta proposes to supply upto 60 mn Sputnik V doses, Haryana govt examining criteria

India TV News  

As India ramps up vaccine production and states float tenders for acquiring additional jabs to speed up the inoculation drive in the country and fight pandemic, the Haryana government on Saturday informed that an international pharma company has given an expression of interest to provide upto 60 million doses of Russia's Sputnik V vaccine at a cost of Rs 1,120 …

SII gets DCGI’s nod to manufacture Sputnik
3 years, 6 months ago

SII gets DCGI’s nod to manufacture Sputnik

Hindustan Times  

The Drugs Controller General of India on Friday granted permission to Serum Institute of India to manufacture Sputnik V, which will allow the production of doses for testing. Sputnik V is currently being distributed in India by Dr Reddy’s Laboratories, which signed a pact with the Russian Direct Investment Fund, which globally markets the Covid-19 vaccine developed by Russia’s Gamaleya …

Serum Institute gets DCGI’s nod to manufacture Covid vaccine Sputnik V in India: Report
3 years, 6 months ago

Serum Institute gets DCGI’s nod to manufacture Covid vaccine Sputnik V in India: Report

Live Mint  

Days after applying to the Drug Controller General of India seeking permission to manufacture the Sputnik V coronavirus jab for examination, test and analysis, the Serum Institute of India has been granted permission by the DCGI. "The DCGI has granted permission to the Serum Institute to manufacture the Sputnik COVID-19 vaccine in India for examination, test and analysis at its …

Serum institute seeks permission to manufacture Sputnik V vaccine in India
3 years, 6 months ago

Serum institute seeks permission to manufacture Sputnik V vaccine in India

Firstpost  

SII said it will be able to manufacture and supply 10 crore Covishield doses in June while also manufacturing Novavax. The Serum Institute of India has applied to the Drug Controller General of India seeking permission to manufacture COVID-19 vaccine Sputnik V in the country, sources said on Thursday. “The Serum Institute of India put up an application to the …

Serum Institute Seeks DCGI's Nod to Manufacture Russian Vaccine Sputnik V in India
3 years, 6 months ago

Serum Institute Seeks DCGI's Nod to Manufacture Russian Vaccine Sputnik V in India

News 18  

After Oxford-AstraZeneca’s Covishield vaccine and Novovax’s Covovax, the Serum Institute of India on Wednesday has applied to get a nod from the Drug Controller General of India to make the Sputnik V Covid-19 vaccine in India. Recently, India received its latest consignment of nearly 3 million doses of the Sputnik V from Russia, making it the third and largest delivery …

No third party authorised to supply Sputnik V vaccine, says Dr. Reddy’s Laboratories
3 years, 6 months ago

No third party authorised to supply Sputnik V vaccine, says Dr. Reddy’s Laboratories

The Hindu  

Reiterating that it has the sole distribution rights of the first 250 million doses of the Russian Sputnik V vaccine in India, Dr. Reddy’s Laboratories on Friday said it has not authorised any third party or intermediary to supply the vaccine on its behalf in the country. Noting that Dr. Reddy’s is the brand custodian of Sputnik V vaccine in …

RDIF, Panacea Biotec launch production of Sputnik V vaccine in India; set to produce 10 mn doses per year
3 years, 7 months ago

RDIF, Panacea Biotec launch production of Sputnik V vaccine in India; set to produce 10 mn doses per year

Firstpost  

The first batch of the COVID-19 vaccine produced at Panacea Biotec’s facilities at Baddi in Himachal Pradesh will be shipped to Russia’s Gamaleya Center for quality control New Delhi: The Russian Direct Investment Fund and Indian drug firm Panacea Biotec on Monday announced the launch of the production of the Sputnik V coronavirus vaccine in India. The first batch of …

2.1 Lakh Sputnik V Doses to be Rolled Out This Week. Will it Help Ease Vaccine Shortage?
3 years, 7 months ago

2.1 Lakh Sputnik V Doses to be Rolled Out This Week. Will it Help Ease Vaccine Shortage?

News 18  

Russia’s Covid-19 vaccine Sputnik V is set to be rolled out this week after the second batch of the shots arrived in India on Sunday. The figure adds up to only 2,10,000 doses of Sputnik V vaccines that is available in India at the moment, which may not play a big factor in easing out the supply chain. The Centre …

‘Sputnik V Production in India to be Ramped Up to 850 Mn Doses a Year, Single-Shot Jab Soon’: Russian Envoy
3 years, 7 months ago

‘Sputnik V Production in India to be Ramped Up to 850 Mn Doses a Year, Single-Shot Jab Soon’: Russian Envoy

News 18  

Production of Sputnik V in India is expected to be gradually ramped up to produce 850 million doses per year, said Russian Ambassador to India N. Kudashev on Sunday. The envoy said Sputnik V is a “Russian-Indian vaccine”, adding that they expect its production in India to be gradually increased, news agency ANI reported. We expect that its production in …

250 Million Sputnik Doses For India in 8-10 Months, Says Dr Reddy's Executive
3 years, 7 months ago

250 Million Sputnik Doses For India in 8-10 Months, Says Dr Reddy's Executive

News 18  

India will receive a total of 250 million doses of Russia’s Sputnik V over the next 8-10 months and its production here is expected to begin from July, a top executive at Dr Reddy’s, the local partner for the vaccine against Covid-19, said on Friday. Dr Reddy’s Laboratories soft-launched Sputnik V in India on Friday with imported doses, as Sapra …

Dr Reddy's Laboratories launches Sputnik V COVID-19 vaccine in India at Rs 995 per dose
3 years, 7 months ago

Dr Reddy's Laboratories launches Sputnik V COVID-19 vaccine in India at Rs 995 per dose

Firstpost  

The Hyderabad-based pharma company said that the first dose of the vaccine was administered to a beneficiary as part of a ’limited pilot' New Delhi: Drug firm Dr Reddy’s Laboratories on Friday said it has launched COVID-19 vaccine Sputnik V in the Indian market with the first dose being administered in Hyderabad, as part of a limited pilot. The company …

Sputnik V vaccine priced at Rs 995 per dose in India, first shot administered by Dr Reddy's in Hyderabad
3 years, 7 months ago

Sputnik V vaccine priced at Rs 995 per dose in India, first shot administered by Dr Reddy's in Hyderabad

India Today  

One dose of imported Sputnik V Covid-19 vaccine will cost Rs 995.40 in India, drug firm Dr Reddy's Laboratories said on Friday. Sputnik V efficacy and how it works Russia’s Sputnik V vaccine, to be administered in two doses, is 91.6% effective in preventing people from developing Covid-19. The soft launch of the Covid vaccine Sputnik V has commenced and …

Sputnik V vaccine to be available in market from next week: Govt
3 years, 7 months ago

Sputnik V vaccine to be available in market from next week: Govt

India TV News  

As India battles with the second wave of coronavirus, NITI Aayog member VK Paul on Thursday said that the Sputnik V vaccine will be available in the market by next week. "We hope Sputnik V vaccine will be available in market by next week," VK Paul said. Meanwhile, NITI Aayog member VK Paul also said, "India will examine the claim …

Sputnik V to be available in India from May | Exclusive interview with Dr Reddy's Deepak Sapra
3 years, 7 months ago

Sputnik V to be available in India from May | Exclusive interview with Dr Reddy's Deepak Sapra

India Today  

Russian Covid-19 vaccine Sputnik V will be available in India from May, a senior official at Dr Reddy’s Laboratories told India Today TV. In an exclusive interview with India Today TV, Deepak Sapra, the CEO of Dr Reddy’s Laboratories, said that the first batch of the vaccine will be imported from Russia. Dr Reddy’s Laboratories managed clinical trials of Sputnik …

Imported Sputnik V to be available this quarter: Dr. Reddy’s
3 years, 8 months ago

Imported Sputnik V to be available this quarter: Dr. Reddy’s

The Hindu  

A day after India accorded emergency use authorisation to Sputnik V, marketing partner for the Russian COVID-19 vaccine Dr. Reddy’s Laboratories said the imported product will be available in the country by this quarter. The contract with Russian Direct Investment Fund, which has partnered Dr. Reddy’s for clinical trials and distribution, is 250 million vaccine units. Dr. Reddy’s has lined …

Dr Reddy's to Start Importing Russia-made Sputnik V Vaccine in April-June, Price under Discussion
3 years, 8 months ago

Dr Reddy's to Start Importing Russia-made Sputnik V Vaccine in April-June, Price under Discussion

News 18  

Dr Reddy’s Laboratories will start importing bulk doses of its anti-coronavirus vaccine Sputnik V from Russia between mid-April to June. According to a contract signed between Hyderabad-based Dr Reddy’s Laboratories and Russian Direct Investment Fund, India will receive about 250 million doses of Sputnik V that would be sufficient for 125 million people. Cold Storage Dr Reddy’s said it has …

Sputnik V vaccine gets DCGI nod for emergency use
3 years, 8 months ago

Sputnik V vaccine gets DCGI nod for emergency use

Hindustan Times  

The drugs controller general of India, VG Somani, on Tuesday approved the Covid-19 vaccine developed by Russia’s Gamaleya Research Institute, Sputnik V, for emergency use in India, a day after the regulator’s subject expert committee recommended that there was enough data to grant the vaccine emergency use authorisation. Dr Reddy’s, which is conducting clinical trials in India on behalf of …

Russia Says 50 Million Doses of Sputnik V Vaccine Production Expected Per Month in India
3 years, 8 months ago

Russia Says 50 Million Doses of Sputnik V Vaccine Production Expected Per Month in India

News 18  

The Russian Direct Investment Fund on Tuesday said it expects over 50 million doses of Sputnik V vaccine to be manufactured in India by this summer. The Drug Controller General of India on Monday registered the vaccine under the emergency use authorisation procedure, based on results of clinical trials in Russia, as well as positive data of additional Phase III …

India to Produce 850 Million Sputnik V Doses Annually, Rollout from End of April or Early May: RDIF
3 years, 8 months ago

India to Produce 850 Million Sputnik V Doses Annually, Rollout from End of April or Early May: RDIF

News 18  

The Russian Direct Investment Fund has said more than 850 million doses of the Sputnik V vaccine are going to be produced annually in India, which has also given approval for the emergency use of the vaccine against coronavirus infections in the country. Kirill Dmitriev, CEO RDIF told CNBC-TV18, “Sputnik V will be priced lower for the Indian market, working …

Amid COVID surge, India fast-tracks approval for foreign vaccines
3 years, 8 months ago

Amid COVID surge, India fast-tracks approval for foreign vaccines

Al Jazeera  

India to approve all vaccines that have been given an emergency nod by WHO or regulators in the US, Europe, Britain or Japan. Vaccines authorised by the World Health Organization or authorities in the United States, Europe, the United Kingdom and Japan “may be granted emergency use approval in India, mandating the requirement of post-approval parallel bridging clinical trial,” the …

Expert panel approves Russia's Sputnik V COVID-19 vaccine in India
3 years, 8 months ago

Expert panel approves Russia's Sputnik V COVID-19 vaccine in India

The Hindu  

Russia’s COVID vaccine — Sputnik V — has been recommended for emergency use authorisation in India following a meeting of the Subject Expert Committee on Monday, The Hindu has confirmed. “The vaccine’s efficacy is confirmed at 91.6% based on the analysis of data on 19,866 volunteers, who received both the first and second doses of the Sputnik V vaccine or …

Russia’s Sputnik V Covid shot may get emergency use nod in India soon: Report
3 years, 8 months ago

Russia’s Sputnik V Covid shot may get emergency use nod in India soon: Report

Live Mint  

New Delhi: As more and more states flag shortage of COVID-19 vaccine doses, the Central government has pressed the accelerator to scale up vaccine production manifold. Explaining the new strategy to manufacture additional vaccine doses, a source said "India currently has 2 COVID-19 vaccines being manufactured locally: Covishield and Covaxin, and we can expect five more vaccines by Q3 2021. …

RDIF, Panacea Biotec to Produce 100 Million Doses of Sputnik Vaccine in India Per Year
3 years, 8 months ago

RDIF, Panacea Biotec to Produce 100 Million Doses of Sputnik Vaccine in India Per Year

News 18  

New Delhi: The Russian Direct Investment Fund and drug firm Panacea Biotec on Monday said they have agreed to produce 100 million doses per year of Sputnik V COVID-19 vaccine in India. Production of Sputnik V at Panacea Biotec sites will help facilitate global supply of Sputnik V to international partners of RDIF, a joint statement said. "Cooperation with Panacea …

India's Virchow Biotech to make 200 million doses of Russia's Sputnik V shot
3 years, 9 months ago

India's Virchow Biotech to make 200 million doses of Russia's Sputnik V shot

India Today  

Russia's RDIF sovereign wealth fund said on Monday it had reached an agreement with India's Virchow Biotech to produce up to 200 million doses a year of the Sputnik V vaccine in India. "Virchow's proven capabilities in large-scale drug substance manufacturing should help meet the global demand for this vaccine," Dr. Tummuru Murali, Managing Director of Virchow Biotech, said in …

India's Covid-19 Vaccine Innovation And Development Strategy Wins WHO Praise
3 years, 9 months ago

India's Covid-19 Vaccine Innovation And Development Strategy Wins WHO Praise

News 18  

New Delhi: India has shown the capacity to be a global-scale manufacturer and also an innovator when it comes to coronavirus vaccines, World Health Organization’s Chief Scientist Soumya Swaminathan said Monday. Speaking at the Global Bio-India 2021, she opined that the fight against the coronavirus pandemic is at a very critical junction now as cases have suddenly gone up, particularly …

Russia's Sputnik V Covid Vaccine Found to be Over 91% Effective, Expects India Approval Soon
3 years, 10 months ago

Russia's Sputnik V Covid Vaccine Found to be Over 91% Effective, Expects India Approval Soon

News 18  

India is expected to grant emergency use authorization for Russia’s Sputnik V COVID-19 vaccine this month or next, the Russian Direct Investment Fund, which markets the shot abroad, told Indian news agency ANI on Tuesday. India is a key partner in terms of production of vaccine and we expect that there’ll be a restricted emergency use order for the Sputnik …

India to produce over 300 million doses of Sputnik-V vaccine against coronavirus
4 years ago

India to produce over 300 million doses of Sputnik-V vaccine against coronavirus

India TV News  

India may produce around 300 million doses of Russia's Sputnik V coronavirus vaccine in 2021, says Kirill Dmitriev, CEO of Russian Direct Investment Fund. "The efficacy of the Sputnik V vaccine is 91.4 per cent, based on the final control point analysis of data obtained 21 days after administering the first dose," Gamaleya Center and the Russian Direct Investment Fund …

India to produce 300 million doses of Sputnik V vaccine as Russia signs more deals
4 years ago

India to produce 300 million doses of Sputnik V vaccine as Russia signs more deals

India Today  

India is all set to produce 300 million doses of the Russian Covid-19 vaccine Sputnik V next year, according to a Russian official who said deals have been signed more Indian manufacturers. Russia is already testing the first samples of the Sputnik V vaccine that were produced in India, according to a tweet by its embassy in New Delhi, reported …

Dr Reddy's, RDIF commence clinical trials for Sputnik V COVID-19 vaccine in India
4 years ago

Dr Reddy's, RDIF commence clinical trials for Sputnik V COVID-19 vaccine in India

India TV News  

Dr Reddy's Laboratories and Russian Direct Investment Fund on Tuesday said they have commenced adaptive phase 2/3 clinical trials for the Sputnik V COVID-19 vaccine in India. Further, Dr Reddy's has partnered with the Biotechnology Industry Research Assistance Council, Department of Biotechnology for advisory support and to use BIRAC's clinical trial centres for the vaccine, it added. "We are working …

Dr Reddy's, RDIF start clinical trials for Russia's Sputnik V vaccine in India
4 years ago

Dr Reddy's, RDIF start clinical trials for Russia's Sputnik V vaccine in India

India Today  

Hyderabad-based Dr Reddy's Laboratories and Russian Direct Investment Fund on Tuesday announced that they have started adaptive Phase 2/3 clinical trials for Sputnik V Covid-19 vaccine candidate in India. Apart from this, Dr Reddy's has partnered with the Biotechnology Industry Research Assistance Council and the Department of Biotechnology for advisory support and to use BIRAC's clinical trial centres for trails …

Russia’s Sputnik V covid vaccine to be produced in India
4 years ago

Russia’s Sputnik V covid vaccine to be produced in India

Live Mint  

Russian Direct Investment Fund and Indian pharma company Hetero, have agreed to produce in India over 100 million doses per year of Sputnik V covid vaccine in India, Russia's sovereign wealth fund said. RDIF on November 24 had announced positive results obtained during the second interim data analysis of the largest double-blind, randomized, placebo-controlled Phase III clinical trials in Russia …

Russia to produce its coronavirus vaccine Sputnik V in India from 2021 beginning
4 years ago

Russia to produce its coronavirus vaccine Sputnik V in India from 2021 beginning

India Today  

The Russian Direct Investment Fund, Russia's sovereign wealth fund, and Hetero, one of India's leading generic pharmaceutical companies have agreed to produce in India over 100 million doses per year of the Sputnik V vaccine against the novel coronavirus infection. Hetero and the Russian Direct Investment Fund, which has been backing the vaccine and marketing it globally, plan to start …

Coronavirus vaccine update: Russia says Sputnik V to be cheaper than US vaccines, SII keeps 'India first' for AstraZeneca vaccine
4 years, 1 month ago

Coronavirus vaccine update: Russia says Sputnik V to be cheaper than US vaccines, SII keeps 'India first' for AstraZeneca vaccine

India Today  

After the Oxford-AstraZeneca coronavirus vaccine showed results that were 70% effective in preventing Covid-19 among volunteers, the company has said the vaccine could go on to be 90% effective. Its earlier announcement of the coronavirus vaccine being 70% effective came as a dampener as 3 other vaccines, Pfizer, Moderna and Russia’s Sputnik V had over 90% effective vaccines in the …

Sputnik V vaccine’s early efficacy trial data expected this month, says RDIF
4 years, 1 month ago

Sputnik V vaccine’s early efficacy trial data expected this month, says RDIF

Live Mint  

New Delhi: The Russian Direct Investment Fund on Monday said that it plans to release interim data from its efficacy trials of Sputnik V vaccine in its home country later this month. We also expect to publish interim efficacy data of Sputnik V clinical trials in November," RDIF chief executive officer Kirill Dmitriev said, while “welcoming” the successful interim efficacy …

Russian vaccine maker ties up with Dr Reddy's Labs for supply of 100 million doses of Sputnik-V shot in India
4 years, 3 months ago

Russian vaccine maker ties up with Dr Reddy's Labs for supply of 100 million doses of Sputnik-V shot in India

India Today  

The Russian Direct Investment Fund on Wednesday said it will supply Dr. Reddy’s Laboratories with 100 million doses of the Sputnik-V Covid-19 vaccine for trial and distribution in India. The RDIF, which is Russia’s sovereign wealth fund, said it has agreed to cooperate with Dr.Reddy's Laboratories on clinical trials and distribution of the vaccine in India. "Upon regulatory approval in …

Unlike AstraZeneca’s Covid-19 vaccine, Sputnik-V is based on a well-studied platform: RDIF CEO
4 years, 3 months ago

Unlike AstraZeneca’s Covid-19 vaccine, Sputnik-V is based on a well-studied platform: RDIF CEO

Live Mint  

New Delhi: Russia's sovereign wealth fund CEO on Saturday said he's 'delighted' that AstraZeneca has resumed trials of its Covid-19 vaccines but said the suspension of trials "clearly showed fallacy of their approach". Suspension of trials clearly showed fallacy of the approach, when entire countries exclusively rely on novel and untested platforms when choosing a vaccine for widespread use, including …

‘Significant movement' on Phase-3 trial, manufacture of Russia's Sputnik V vaccine, says NITI Aayog
4 years, 3 months ago

‘Significant movement' on Phase-3 trial, manufacture of Russia's Sputnik V vaccine, says NITI Aayog

Firstpost  

Dr VK Paul, who chairs the national expert group on COVID-19 vaccine administration, said that the government of India attaches ‘great importance to this offer of partnership from a friend’ New Delhi: India is considering Russia’s request for conducting phase-3 clinical trial and manufacturing of its COVID-19 vaccine Sputnik V by Indian firms, officials said Tuesday, noting there have been …

Discover Related